- Regeneron's US macular edema win barely noticed by investors
- CHMP positive opinion on Eylea will stir up EU AMD market
- Compounder Clinical Specialties expands recall, FDA alerts
- JP MORGAN 2013: Eylea, other star launches attract investor attention
ONLY 0 DAY LEFT
|Stay close to your market. Renew online now to ensure uninterrupted access to:|
|SCRIP Intelligence's news and expert commentary|
|Market Data and Company Analysis (SCRIP 100, SCRIP Asia 100)|
|The Ask the Analyst Service...and more.|
Please remember to quote your order number and customer number.
You can also renew by calling: +44 (0)20 7017 5540.